These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 9924299

  • 41. Mitomycin-C and vernal conjunctivitis.
    MacLeod JD.
    Ophthalmology; 2000 Dec; 107(12):2127. PubMed ID: 11097580
    [No Abstract] [Full Text] [Related]

  • 42. N-acetyl-aspartyl-glutamic acid inhibits cellular recruitment and mediator release during the late allergen-induced nasal reaction.
    Miadonna A, Milazzo N, Salmaso C, Cottini M, Lorini M, Tedeschi A.
    Eur J Clin Pharmacol; 1998 Sep; 54(7):515-20. PubMed ID: 9832292
    [Abstract] [Full Text] [Related]

  • 43. Vernal keratoconjunctivitis in Thailand.
    Kosrirukvongs P, Vichyanond P, Wongsawad W.
    Asian Pac J Allergy Immunol; 2003 Mar; 21(1):25-30. PubMed ID: 12931748
    [Abstract] [Full Text] [Related]

  • 44. A randomized, double-masked, placebo-controlled parallel study of loteprednol etabonate 0.2% in patients with seasonal allergic conjunctivitis.
    Shulman DG, Lothringer LL, Rubin JM, Briggs RB, Howes J, Novack GD, Hart K.
    Ophthalmology; 1999 Feb; 106(2):362-9. PubMed ID: 9951491
    [Abstract] [Full Text] [Related]

  • 45. Protective effect opf lodoxamide tromethamine on allergen inhalation challenge.
    Watt GD, Bui TC, Bewtra AK, Townley RG.
    J Allergy Clin Immunol; 1980 Oct; 66(4):286-94. PubMed ID: 7419830
    [Abstract] [Full Text] [Related]

  • 46. [Alomide eyedrops in the treatment of allergic conjunctivitis and keratoconjunctivitis].
    Maĭchuk IuF, Khaitova KN, Grishakova MB.
    Vestn Oftalmol; 1998 Oct; 114(4):43-4. PubMed ID: 9771090
    [Abstract] [Full Text] [Related]

  • 47. [NAAGA and cromoglycate. A comparison in the treatment of seasonal allergic rhinitis].
    Datz B, Sieger C, Weibel MA.
    Laryngol Rhinol Otol (Stuttg); 1988 Jun; 67(6):300-3. PubMed ID: 3136279
    [Abstract] [Full Text] [Related]

  • 48. Lodoxamide tromethamine treatment for superior limbic keratoconjunctivitis.
    Grutzmacher RD, Foster RS, Feiler LS.
    Am J Ophthalmol; 1995 Sep; 120(3):400-2. PubMed ID: 7661218
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Contact lens induced conjunctivitis: a model of human ocular inflammation.
    Friedlaender MH.
    CLAO J; 1996 Jul; 22(3):205-8. PubMed ID: 8828938
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Comparison of efficacy of bromfenac sodium 0.1% ophthalmic solution and fluorometholone 0.02% ophthalmic suspension for the treatment of allergic conjunctivitis.
    Fujishima H, Fukagawa K, Takano Y, Tanaka M, Okamoto S, Miyazaki D, Yamada J, Fukushima A, Uchio E, Nakagawa Y.
    J Ocul Pharmacol Ther; 2009 Jun; 25(3):265-70. PubMed ID: 19348602
    [Abstract] [Full Text] [Related]

  • 55. Efficacy and safety of 0.1% lodoxamide for the long-term treatment of superior limbic keratoconjunctivitis.
    Rodriguez-Garcia A, Macias-Rodriguez Y, Gonzalez-Gonzalez JM.
    Int Ophthalmol; 2018 Jun; 38(3):1243-1249. PubMed ID: 28602013
    [Abstract] [Full Text] [Related]

  • 56. Lodoxamide as adjuvant therapy in patients with dry eye.
    Petricek I, Pokupec R, Petricek G, Salopek-Rabatić J.
    Coll Antropol; 2001 Jun; 25 Suppl():149-52. PubMed ID: 11817007
    [Abstract] [Full Text] [Related]

  • 57. [Clinical evaluation of N-acetylaspartylglutamic acid eyedrops in subacute and chronic atopic conjunctivitis].
    van Bijsterveld OP, Aalders-Deenstra V.
    Klin Monbl Augenheilkd; 1986 Jun; 188(6):625-7. PubMed ID: 3093750
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Pemirolast potassium 0.1% ophthalmic solution is an effective treatment for allergic conjunctivitis: a pooled analysis of two prospective, randomized, double-masked, placebo-controlled, phase III studies.
    Abelson MB, Berdy GJ, Mundorf T, Amdahl LD, Graves AL, Pemirolast study group.
    J Ocul Pharmacol Ther; 2002 Oct; 18(5):475-88. PubMed ID: 12419098
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.